Igor Bruzual

663 total citations
12 papers, 262 citations indexed

About

Igor Bruzual is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Igor Bruzual has authored 12 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 4 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Igor Bruzual's work include Antifungal resistance and susceptibility (4 papers), Toxoplasma gondii Research Studies (4 papers) and Fungal Infections and Studies (4 papers). Igor Bruzual is often cited by papers focused on Antifungal resistance and susceptibility (4 papers), Toxoplasma gondii Research Studies (4 papers) and Fungal Infections and Studies (4 papers). Igor Bruzual collaborates with scholars based in United States, Venezuela and Brazil. Igor Bruzual's co-authors include Charles E. Gast, Brian Wong, Carol A. Kumamoto, Susan Hadley, Perry J. Riggle, Sovitj Pou, J. Stone Doggett, Michael K. Riscoe, Aaron Nilsen and Rolf W. Winter and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Igor Bruzual

12 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Igor Bruzual United States	8	133	124	95	58	29	12	262
Sergio Sifontes Cuba	10	98 0.7×	91 0.7×	24 0.3×	56 1.0×	69 2.4×	42	338
Cátia Lacerda Sodré Brazil	11	174 1.3×	102 0.8×	25 0.3×	104 1.8×	90 3.1×	19	317
Robert Schaer Brazil	12	125 0.9×	80 0.6×	30 0.3×	84 1.4×	21 0.7×	23	378
Simon Paul United States	6	288 2.2×	224 1.8×	45 0.5×	148 2.6×	59 2.0×	8	465
Sarah S. Bubeck United States	8	73 0.5×	92 0.7×	45 0.5×	162 2.8×	27 0.9×	11	337
Philippe Lawton France	12	124 0.9×	59 0.5×	209 2.2×	55 0.9×	86 3.0×	32	368
Setareh Agha Kuchak Afshari Iran	10	126 0.9×	120 1.0×	18 0.2×	55 0.9×	65 2.2×	32	275
Małgorzata Kowalczewska France	11	35 0.3×	93 0.8×	165 1.7×	70 1.2×	60 2.1×	25	314
Angelita dos Reis Gomes Brazil	7	100 0.8×	194 1.6×	13 0.1×	123 2.1×	22 0.8×	33	325
Ashutosh Panda India	10	79 0.6×	107 0.9×	48 0.5×	69 1.2×	66 2.3×	29	305

Countries citing papers authored by Igor Bruzual

Since Specialization

Citations

This map shows the geographic impact of Igor Bruzual's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Bruzual with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Bruzual more than expected).

Fields of papers citing papers by Igor Bruzual

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Bruzual. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Bruzual. The network helps show where Igor Bruzual may publish in the future.

Co-authorship network of co-authors of Igor Bruzual

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Bruzual. A scholar is included among the top collaborators of Igor Bruzual based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Bruzual. Igor Bruzual is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Doggett, J. Stone, Tracey L. Schultz, Alyssa J. Miller, et al.. (2020). Orally Bioavailable Endochin-Like Quinolone Carbonate Ester Prodrug Reduces Toxoplasma gondii Brain Cysts. Antimicrobial Agents and Chemotherapy. 64(9). 22 indexed citations

Smilkstein, Martin J., Sovitj Pou, Rozalia A. Dodean, et al.. (2019). ELQ-331 as a prototype for extremely durable chemoprotection against malaria. Malaria Journal. 18(1). 291–291. 13 indexed citations

Hulverson, Matthew A., Igor Bruzual, Wenlin Huang, et al.. (2018). Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis. The Journal of Infectious Diseases. 219(9). 1464–1473. 11 indexed citations

Bruzual, Igor, Sovitj Pou, Rolf W. Winter, et al.. (2018). Targeted Structure–Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc₁ and Identifies ELQ-400 as a Remarkably Effective Compound against Acute Experimental Toxoplasmosis. ACS Infectious Diseases. 4(11). 1574–1584. 30 indexed citations

Bruzual, Igor, Aaron Nilsen, Sovitj Pou, et al.. (2016). Genetic Evidence for Cytochrome b Q _i Site Inhibition by 4(1 H )-Quinolone-3-Diarylethers and Antimycin in Toxoplasma gondii. Antimicrobial Agents and Chemotherapy. 61(2). 48 indexed citations

Gast, Charles E., et al.. (2015). Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans. Journal of Antimicrobial Chemotherapy. 70(5). 1396–1407. 43 indexed citations

Gast, Charles E., et al.. (2013). Azole Resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the Role of ERG11. Antimicrobial Agents and Chemotherapy. 57(11). 5478–5485. 34 indexed citations

Bruzual, Igor & Carol A. Kumamoto. (2011). An MDR1 promoter allele with higher promoter activity is common in clinically isolated strains of Candida albicans. Molecular Genetics and Genomics. 286(5-6). 347–357. 6 indexed citations

Bruzual, Igor, Perry J. Riggle, Susan Hadley, & Carol A. Kumamoto. (2007). Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole. Journal of Antimicrobial Chemotherapy. 59(3). 441–450. 47 indexed citations

10.

Alonso, Guillermina, et al.. (2002). Characterization of plasmid MIP233 (IncHI3) of the H complex. Research in Microbiology. 153(3). 149–153. 4 indexed citations

11.

Alonso, Guillermina, et al.. (2000). Construction of a cassette for cloning and analysis of replicons.. PubMed. 51(1). 4–9. 1 indexed citations

12.

Alonso, Guillermina, et al.. (1999). Cloning and characterization of a replicon region of the IncHII plasmid pHH1457. FEMS Microbiology Letters. 179(2). 361–366. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact